3World Health Organization Anti-tuberculosis drug resistance in the Geneva:WHO IUATLD Global project on Anti-tuberculosis Drug Resistance Surellunce 1994-1997.WHO Global Tuberculosis Progress
5Tsao T C Y,Chion W.Clinical and epidemiological study: change in demographic picture and increase of drug resistance in pulmonary tuberculosis in a 10-year interval in taiwan.infection,2002,30(2) :75～80
6Coleounders R .Lambert M L.Management of co-infection with HIV and TB.British Medical Journal,2002,324 (7341 ): 802 ～ 803
7Hanan M M ,Azadian B S.Hospital infection control in an era of HIV infection and multidrug resistant tuberculosis.Journal of Hospital Infection,2000,44 ( 1 ): 5 ～ 11
9Lilly KW,David L,Peter JC.Bacteriological and molecular analysis of rifampin-resistant mycobacterium tubercular strain isolated in Australia.J Clin Microbiol,1999,37(12) :3844～3850
10Alvarado-Esquivel C,Rossau R,Martiaez-Gatcia S,et al.Characterization of rpoB gene mutation in rifampin resistant mycobacterium tubercular strain isolated from pulmonary mycobacterium tuberculosis patients at 5 Mexican Public Hospitals,Rev Invest Clin,2001,53(6):526～530
二级参考文献13
1Cohn D. L,Bustreo F,Raviglione M. C. Drug-Resistant Tubercalosis:Revicw of Worldwide Sifuation and the WHO/IUATLD Global Surveillance Project Clinical Infectious Disseases, 1997 ; 24: 121 ～130.
2Moore,Onorato I. M,McCray E,et al. Treud in Drug-Resistant Tubereulosis in the Unitcd Stalas, 1993-1998 JAMA,September 10,1997 ; 1278:833～887.
3Teylor J. P,Sweat D. B,Suarez L,. Epidemiology of Drug-Resistant Tubercalosis in Texas. Am J Epidemd, 1999 ; 149: 359～365.
4Y.P. Hong,S. J. Kim. W. J. Lew,et al:The seventh Nationwide Tubercalosis Prevalance Survey in Korea 1995. Int. J. Tubarc Lung Dis,2(1) :27～36.
